State of New Jersey Common Pension Fund D reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 4.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,344 shares of the company’s stock after selling 1,865 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Henry Schein were worth $3,160,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently modified their holdings of HSIC. Swedbank AB purchased a new position in Henry Schein during the first quarter valued at $215,998,000. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein in the second quarter worth about $46,683,000. SG Americas Securities LLC lifted its position in shares of Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after buying an additional 432,187 shares in the last quarter. Private Management Group Inc. bought a new position in Henry Schein during the third quarter valued at approximately $24,176,000. Finally, Magnetar Financial LLC grew its holdings in Henry Schein by 229.9% during the 1st quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock valued at $29,185,000 after buying an additional 269,330 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently commented on HSIC. Robert W. Baird lowered their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. JPMorgan Chase & Co. reduced their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. UBS Group reduced their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $77.50.
Insiders Place Their Bets
In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 1.14% of the company’s stock.
Henry Schein Trading Down 1.2 %
NASDAQ HSIC opened at $67.46 on Wednesday. The stock has a market cap of $8.41 billion, a PE ratio of 27.76, a PEG ratio of 1.95 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The company’s 50-day moving average price is $70.40 and its 200-day moving average price is $69.63. The company has a current ratio of 1.42, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the firm earned $1.32 EPS. The company’s revenue for the quarter was up .4% compared to the same quarter last year. Equities research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- What Are Dividend Champions? How to Invest in the Champions
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- 3 Healthcare Dividend Stocks to Buy
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Invest in Small Cap StocksĀ
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.